Quantcast

Latest Clinical research Stories

2014-08-18 08:28:40

SHANGHAI, Aug. 18, 2014 /PRNewswire/ -- WuXiPharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that a manufacturing facility of WuXi's wholly owned subsidiary Shanghai SynTheAll Pharmaceutical Co. Ltd. (STA) passed an FDA inspection in July for the manufacture of the active pharmaceutical ingredient (API) for a branded commercial drug. This...

2014-08-14 23:11:14

With 15 interactive exercises, this workshop, taught by internationally renowned medical device process validation expert Dan O’Leary, is designed to provide industry best practices to achieve sustainable process validation with regulatory bodies around the world. Attendees will learn the theories of process validation and documentation and how to put them into practice. Falls Church, VA (PRWEB) August 14, 2014 Innovative Process Validation Strategies for Medical Devices: Proving Your...

2014-08-14 23:01:16

The Firm is representing numerous individuals who allegedly suffered life-threatening cardiovascular injuries prior to the 2012 NaturaLyte and GranuFlo recall. New York, NY (PRWEB) August 14, 2014 A U.S. Food and Drug Administration (FDA) initiative that allows public access to product recall information reveals that actions similar to one that has since prompted thousands of GranuFlo lawsuits (http://www.thegranuflolawsuit.com/) have increased dramatically over the past few years,...

2014-08-14 16:27:44

Company To Pursue Next Stage of Development REDWOOD CITY, Calif., Aug. 14, 2014 /PRNewswire/ -- Coherus BioSciences, Inc. ("Coherus") today announced that CHS-1420, its proposed biosimilar of adalimumab (Humira®), met the primary endpoint in a pivotal clinical pharmacokinetic (PK) similarity study that compared CHS-1420 to Humira(®) in healthy subjects. The parallel-group, single-dose study met the criteria for clinical PK similarity on all three required, prospectively defined,...

2014-08-14 16:27:40

Signs Business Collaboration in South Korea with Wonik Corporation BRIDGEWATER, N.J., Aug. 14, 2014 /PRNewswire/ -- CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal and infectious disease, today announced the U.S. Food and Drug Administration (FDA) has agreed with the design of our pivotal Phase III protocol for Neutrolin® in Hemodialysis patients, and the company...

2014-08-14 08:30:05

First Patient Dosed in the EU Post-Authorization Safety Study MOUNTAIN VIEW, Calif., Aug. 14, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today provided an update on its European Medicines Agency (EMA) post-approval studies for ADASUVE(®) inhalation powder, pre-dispensed (loxapine). As part of the ADASUVE approval process with the EMA, Alexza is required to conduct five post-approval studies: -- a benzodiazepine interaction study - study completed and data...

2014-08-13 23:09:49

On August 7, the US FDA informed consumers that two lots of RegeneSlim appetite control capsules, by Regeneca Worldwide, were recalled due to presence of DMAA. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) August 13, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on appetite control capsules. The FDA...

2014-08-13 23:03:42

Researchmoz.us announces addition of new report "Neuropathy Global Clinical Trials Review, H2, 2014" to its database. Albany, NY (PRWEB) August 13, 2014 "Clinical trial report, Neuropathy Global Clinical Trials Review, H2, 2014" provides data on the Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuropathy. It includes an overview of the trial numbers and their recruitment status as per the...

2014-08-13 12:28:41

-- Analysis of over 17,000 cases finds that clinical performance of PanoramaTM NIPT is consistent in high and low risk populations -- SAN CARLOS, Calif., Aug. 13, 2014 /PRNewswire/ -- Natera, Inc., a leader in non-invasive genetic testing, today announced a study to be published in the November issue of American Journal of Obstetrics and Gynecology, which shows that Panorama(TM) NIPT performs consistently well in all pregnant women, regardless of their prior risk level. This is the largest...

2014-08-13 08:29:58

Phase III Trial Is Alive And Well; "Hint Of Failure" A Complete Fabrication; No Interim Analysis of Efficacy Done; 55 Patients' Positive Data Independently Collected. BETHESDA, Md., Aug. 13, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today corrected ongoing false claims by Adam Feuerstein published on the TheStreet.com about the Company's Phase III trial of DCVax-L...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related